Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Danaher (DHR). But which of these two companies is the best option for those looking for underva
Solventum posts strong Q3 results with a revenue and earnings beat, lifts 2025 EPS guidance on solid MedSurg and HIS growth.
Solventum Corporation ( SOLV ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan
While the top- and bottom-line numbers for Solventum (SOLV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics com
Solventum (SOLV) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.64 per share a year ago.
Reported sales increased 0.7%; organic sales increased 2.7% Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range Increases full year adjusted earnings per share outlook
/PRNewswire/ -- Independent Power Producer Matrix Renewables and EPC contractor SOLV Energy today celebrated the completion of the Stillhouse Solar project
Get a deeper insight into the potential performance of Solventum (SOLV) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for
Solventum (NYSE: SOLV - Get Free Report) and KindlyMD (NASDAQ: NAKA - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the st
Solventum's Q3 results may reflect softer sales and tariff impacts, though pricing discipline and core growth drivers likely aided margins.
ST. PAUL, Minn. , Nov. 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, Nov. 12, 202
Solventum (SOLV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Asset Management One Co. Ltd. decreased its position in Solventum Corporation (NYSE: SOLV) by 2.3% during the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 60
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE